7th Annual Phase IV Clinical Trials

Design Research Programs to Meet Clinical, Regulatory and Marketing Objectives

CBI’s Annual Recalls Summit

This conference provides the only platform for the industry to discuss critical topics regarding planning for, and navigating through, a product recall.

7th Annual Phase IV Clinical Trials

Design Research Programs to Meet Clinical, Regulatory and Marketing Objectives

Pharmaceutical Product Launch

Driving forces and joint cross functional efforts for a successful global launch

5th Leadership Summit on Strategic Medicare Compliance and Administration

The Premier Conference Convening Manufacturers and Part D Plans to Assess Implementation, Develop Sustainable Strategies and Ensure Compliance

5th Leadership Summit on Strategic Medicare Compliance and Administration

The Premier Conference Convening Manufacturers and Part D Plans to Assess Implementation, Develop Sustainable Strategies and Ensure Compliance

Reporting Drug Safety Research

There are several key areas that will be discussed and debated during this program, including Safety Data Analysis, a risk management framework for drug safety research, the FDA’s guidance document on Post-Marketing Risk Assessment, Good Pharmacovigilancve Practices & Pharmacoepidemiologic Assessment, strategies for effective data transparency and corporate image management, emerging technologies to streamline risk management in drug safety reporting and post-marketing surveillance and best practices in the analysis of this data as well as optimal methods of information delivery.

2nd Annual Drug Repurposing and Repositioning

This conference will focus on identifying suitable compounds and opportunities for repurposing.

2nd Annual Medical Device and Diagnostics Marketing Compliance Congress

Critical Updates on Enforcement Actions, Criminal and Civil Liability and Compliance Tactics Regarding Advertising, Off-Label Promotion and Fraud & Abuse

2nd Annual Medical Device and Diagnostics Marketing Compliance Congress

Critical Updates on Enforcement Actions, Criminal and Civil Liability and Compliance Tactics Regarding Advertising, Off-Label Promotion and Fraud & Abuse

STAY CONNECTED

29,540FollowersFollow
- Advertisement -